Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Interim Management Statement

29 Sep 2008 07:00

RNS Number : 4770E
PZ CUSSONS PLC
29 September 2008
 



29 September 2008 

PZ Cussons Plc

(the "Group")

Interim Management Statement

PZ Cussons Plc today issues the following interim management statement which covers the period 1st June 2008 to 28th September 2008, in advance of its Annual General Meeting, to be held at 12 noon today.

Overview of financial position and performance

The Board is pleased to announce that the performance of the Group during the period has been in line with management expectations. The financial position of the Group remains strong with cash generation during the period also in line with expectations.

The trading outlook for the full year remains positive despite the uncertain and volatile wider economic picture both in the UK and globally.

Regional Reviews

An update of performance and major projects, in particular in the Group's main markets of NigeriaIndonesiaAustralia and the UK is set out below.

Africa

In Nigeria, the Group's main market, the political environment remains stable one year on from the last elections which saw the transition from one democratically elected president to another. Economically, the oil price rise has allowed significant foreign exchange reserves to be accumulated and a small proportion of this is being passed down into the economy. This tight management of the country's wealth is building the platform for future growth. In the short term, Nigeria remains reasonably cushioned from the effects of the global credit crunch, with net consumer wealth continuing to increase as a result of wage rises outstripping cost inflationOur businesses continue to perform well with strong growth in Home Care, Personal Care and Electricals. The Nutrition business, which is experiencing significant swings in milk costs, is anticipated to move into profitability in the second half of the financial year.

The two major investment projects in Nigeria are on schedule. Firstly Project Unity, which is the £39m investment in our core manufacturing facilities, is well underway and will increase the capacity of our factories and upgrade their efficiency to world class standards over the next three years. And secondly, completion of the new Nutrition factory is on schedule for commissioning early in 2009 and will provide manufacturing capability for a brand new range of products in UHT format.

Asia

Whilst the market in Australia continues to be challenging as a result of the competitive environment being driven by the two major retailers, investment in our brands and in margin improvement programmes in the first quarter will provide a strong foundation for the full year.

In Indonesiathe baby brand has experienced good growth in the first quarter and continues to strengthen its number one position in the market. 

Europe

Performance of the UK business continues to be strong across the portfolio of Imperial Leather, Original Source, Carex, Charles Worthington, The Sanctuary and Morning Fresh brands.

There is a strong pipeline of innovative new products across all brands with a large number of new products already launched since the start of the financial year. This innovation is ensuring good growth despite the worsening consumer economic environment and increasingly challenging trade negotiations. The Sanctuary, purchased in January 2008, also continues to perform well building on its strengths of continued brand innovation supported by a loyal consumer base.

Construction of the Group's 'Personal Wash Centre of Excellence' in Manchester, incorporating a new manufacturing facility, a Research and Development Centre and a Fragrance Development Centre, is on schedule. Production has commenced at the new manufacturing facility with the remaining production being transferred by the end of the calendar year. The remainder of the facilities will be completed early in 2009. 

Operational Board and PLC Directors

As highlighted in July, an Operational Board has been created to support the PLC Board in the operational management of the Group's businesses. As part of the planned development of the senior management structure, Graham Calder, Deputy Chairman, will move to a part-time basis with effect from 1 December and Sam Plant, Head of Corporate Services on the Operational Board, has assumed the role of Company Secretary. 

Summary

The overall performance and position of the Group at the end of the period is in line with the Board's expectations.

The trading outlook for the full year remains positive in all territories.  Margin improvement initiatives are in place to mitigate the continued increases in raw material prices which, despite the recent fall in the oil price, remain volatile and well ahead of last year

Currencies are also volatile, although the strengthening of the dollar versus sterling will benefit the Group's results on translation should this continue for the remainder of the year.

Overall, we remain cautiously optimistic for the full year outturn despite the uncertain global economic picture

A further update on the Group's performance will be given in the interim financial statements for the six months to 30th November 2008, to be announced at the end of January 2009.

- Ends -

For further information contact:

PZ Cussons Plc Tel: 0161 491 8000

Graham Calder / Brandon Leigh

Hogarth Partnership Limited Tel: 020 7357 9477

John Olsen / Sarah MacLeod

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFKAKBPBKDNCB
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.